Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease.
Yang WS, Liu Q, Li Y, Li GY, Lin S, Li J, Li LY, Li Y, Ge XL, Wang XZ, Wu W, Yan J, Wang GF, Zhou QT, Liu Q, Wang MW, Li ZP.
Yang WS, et al. Among authors: ge xl.
Acta Pharmacol Sin. 2025 Jul;46(7):1958-1973. doi: 10.1038/s41401-025-01525-7. Epub 2025 Mar 11.
Acta Pharmacol Sin. 2025.
PMID: 40069490